MRNS - Marinus Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5181.13M
Enterprise Value 3145.16M
Trailing P/E N/A
Forward P/E 1-2.90
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)3.12
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-7.67

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Dec 31, 2017

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-25.84%
Return on Equity (ttm)-47.55%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -18.92M
Net Income Avi to Common (ttm)-18.9M
Diluted EPS (ttm)-0.80
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)53.39M
Total Cash Per Share (mrq)1.32
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)21.37
Book Value Per Share (mrq)1.43

Cash Flow Statement

Operating Cash Flow (ttm)-18.82M
Levered Free Cash Flow (ttm)-12.26M

Trading Information

Stock Price History

Beta 3.09
52-Week Change 3194.16%
S&P500 52-Week Change 310.35%
52 Week High 39.87
52 Week Low 31.13
50-Day Moving Average 34.29
200-Day Moving Average 36.10

Share Statistics

Avg Vol (3 month) 31.08M
Avg Vol (10 day) 3457.07k
Shares Outstanding 540.52M
Float 33.02M
% Held by Insiders 11.14%
% Held by Institutions 172.31%
Shares Short 32.84M
Short Ratio 32.04
Short % of Float 317.35%
Shares Short (prior month) 33.19M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A